BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35085554)

  • 1. SRC kinase activator CDCP1 promotes hepatocyte growth factor-induced cell migration/invasion of a subset of breast cancer cells.
    Kawase N; Sugihara A; Kajiwara K; Hiroshima M; Akamatsu K; Nada S; Matsumoto K; Ueda M; Okada M
    J Biol Chem; 2022 Mar; 298(3):101630. PubMed ID: 35085554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDCP1 promotes compensatory renal growth by integrating Src and Met signaling.
    Kajiwara K; Yamano S; Aoki K; Okuzaki D; Matsumoto K; Okada M
    Life Sci Alliance; 2021 Apr; 4(4):. PubMed ID: 33574034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.
    Li W; Xiong X; Abdalla A; Alejo S; Zhu L; Lu F; Sun H
    J Biol Chem; 2018 Oct; 293(40):15397-15418. PubMed ID: 30108175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling.
    Parr C; Ali AY
    J Transl Med; 2018 Oct; 16(1):281. PubMed ID: 30314527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
    Xu H; Washington S; Verderame MF; Manni A
    Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.
    Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
    Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells.
    Huang S; Ouyang N; Lin L; Chen L; Wu W; Su F; Yao Y; Yao H
    PLoS One; 2012; 7(1):e29124. PubMed ID: 22242160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C; Jiang WG
    Int J Oncol; 2001 Oct; 19(4):857-63. PubMed ID: 11562767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzyl isothiocyanate inhibits basal and hepatocyte growth factor-stimulated migration of breast cancer cells.
    Kim EJ; Eom SJ; Hong JE; Lee JY; Choi MS; Park JH
    Mol Cell Biochem; 2012 Jan; 359(1-2):431-40. PubMed ID: 21892609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.
    Murray DW; Didier S; Chan A; Paulino V; Van Aelst L; Ruggieri R; Tran NL; Byrne AT; Symons M
    Br J Cancer; 2014 Mar; 110(5):1307-15. PubMed ID: 24518591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells.
    Usatyuk PV; Fu P; Mohan V; Epshtein Y; Jacobson JR; Gomez-Cambronero J; Wary KK; Bindokas V; Dudek SM; Salgia R; Garcia JG; Natarajan V
    J Biol Chem; 2014 May; 289(19):13476-91. PubMed ID: 24634221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPA, HGF, and EGF utilize distinct combinations of signaling pathways to promote migration and invasion of MDA-MB-231 breast carcinoma cells.
    Harrison SM; Knifley T; Chen M; O'Connor KL
    BMC Cancer; 2013 Oct; 13():501. PubMed ID: 24160245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
    Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
    Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
    Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases.
    Leroy C; Shen Q; Strande V; Meyer R; McLaughlin ME; Lezan E; Bentires-Alj M; Voshol H; Bonenfant D; Alex Gaither L
    Oncogene; 2015 Oct; 34(44):5593-8. PubMed ID: 25728678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
    Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B
    J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
    Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
    Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.